Recombinant Saccharomyces cerevisiae CDA2 Protein (Yeast)，His

CDA2 recombinant protein research is rooted in the growing interest in enzyme therapy and its potential applications in biotechnology and medicine. CDA2, or cytidine deaminase type 2, is an enzyme that plays a crucial role in nucleotide metabolism by catalyzing the deamination of cytidine and deoxycytidine to uridine and deoxyuridine, respectively. This enzymatic activity is significant in various biological processes, including antiviral responses and the regulation of cellular metabolism. Given the importance of nucleotide metabolism in a range of diseases, including cancer and viral infections, understanding CDA2's structure and function through recombinant protein studies can provide insights into its therapeutic potential. Researchers have focused on producing CDA2 in recombinant systems to study its biophysical properties, enzymatic mechanisms, and potential applications in drug development. By utilizing techniques like gene cloning, expression in bacterial systems, and subsequent purification, scientists aim to generate sufficient quantities of the enzyme for further investigations. Additionally, the study of CDA2's interactions with substrates and inhibitors may reveal novel therapeutic strategies for diseases where nucleotide metabolic pathways are dysregulated. Overall, CDA2 recombinant protein research holds promise for advancing our understanding of enzymatic functions and their applications in medicine and biotechnology.